Literature DB >> 11446652

Complement factor H: physiology and pathophysiology.

P F Zipfel1.   

Abstract

The human plasma protein factor H, which is a multifunctional, multidomain protein, acts as a central regulator of the complement system. In addition to its complement regulatory activities, factor H has multiple physiological activities and 1) acts as an extracellular matrix component, 2) binds to cellular receptors of the integrin type, and 3) interacts with a wide selection of ligands, such as the C-reactive protein, thrombospondin, bone sialoprotein, osteopontin, and heparin. Recent genetic reports, which show involvement of factor H in the human disease hemolytic-uremic syndrome (HUS), have attracted the attention of both clinicians and basic complement researchers to the role of factor H in the pathophysiology of HUS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446652     DOI: 10.1055/s-2001-15248

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  24 in total

1.  Adrenomedullin upregulates M2-muscarinic receptors in cardiomyocytes from P19 cell line.

Authors:  Sophie Buys; Fatima Smih; Atul Pathak; Pierre Philip-Couderc; Patrick Verwaerde; Jean-Louis Montastruc; Philippe Rouet; Jean-Michel Senard
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 2.  The role of inflammation in the pathogenesis of age-related macular degeneration.

Authors:  Larry A Donoso; David Kim; Arcilee Frost; Alston Callahan; Gregory Hageman
Journal:  Surv Ophthalmol       Date:  2006 Mar-Apr       Impact factor: 6.048

Review 3.  Progress in defining the molecular biology of age related macular degeneration.

Authors:  Andrew Lotery; Dorothy Trump
Journal:  Hum Genet       Date:  2007-07-21       Impact factor: 4.132

4.  The broad antibacterial activity of the natural antibody repertoire is due to polyreactive antibodies.

Authors:  Zhao-Hua Zhou; Yahong Zhang; Ya-Fang Hu; Larry M Wahl; John O Cisar; Abner Louis Notkins
Journal:  Cell Host Microbe       Date:  2007-03-15       Impact factor: 21.023

5.  Local Inhibition of Complement Improves Mesenchymal Stem Cell Viability and Function After Administration.

Authors:  Yan Li; John Fung; Feng Lin
Journal:  Mol Ther       Date:  2016-07-05       Impact factor: 11.454

6.  MPGN II--genetically determined by defective complement regulation?

Authors:  Christoph Licht; Ursula Schlötzer-Schrehardt; Michael Kirschfink; Peter F Zipfel; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2006-09-23       Impact factor: 3.714

7.  Dense deposit disease associated with monoclonal gammopathy of undetermined significance.

Authors:  Sanjeev Sethi; William R Sukov; Yuzhou Zhang; Fernando C Fervenza; Donna J Lager; Dylan V Miller; Lynn D Cornell; Srivilliputtur G Santhana Krishnan; Richard J H Smith
Journal:  Am J Kidney Dis       Date:  2010-09-15       Impact factor: 8.860

Review 8.  Age-related macular degeneration--emerging pathogenetic and therapeutic concepts.

Authors:  Karen M Gehrs; Don H Anderson; Lincoln V Johnson; Gregory S Hageman
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

9.  Recruitment of complement factor H-like protein 1 promotes intracellular invasion by group A streptococci.

Authors:  Vinod Pandiripally; Lin Wei; Christine Skerka; Peter F Zipfel; David Cue
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 10.  Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal disease.

Authors:  Lisa K McNeil; Robert J Zagursky; Shuo L Lin; Ellen Murphy; Gary W Zlotnick; Susan K Hoiseth; Kathrin U Jansen; Annaliesa S Anderson
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.